05.04.2006 12:30:00

State of Virginia Rapidly Adopting ZOLL AutoPulse

--ZOLL Medical Corporation (NASDAQ: ZOLL), amanufacturer of resuscitation devices and related software solutions,today reported that a growing number of EMS agencies in the state ofVirginia are deploying the AutoPulse to help better manage cardiacarrest. Most recent customers include Goochland County Fire-RescueDepartment, which purchased six devices, and Sterling Volunteer RescueSquad, which purchased seven devices.

Goochland County Fire-Rescue provides 24-hour fire and emergencymedical services to more than 16,800 people in Goochland County, justwest of Richmond, Virginia. "We implemented the AutoPulse countywideat all six of our stations," said Eddie Ferguson, Goochland County'sDeputy Chief of EMS. "After several uses, the AutoPulse has yieldedpositive results. Beyond the increased perfusion benefits that we haveseen our patients gain, the AutoPulse allows for a more efficientlyrun code, impacting our providers and EMS system in a positive andsafe way. I would highly recommend the AutoPulse to any EMS systemwishing to improve its resuscitation effectiveness."

Sterling Volunteer Rescue Squad offers emergency services toapproximately 70,000 people over 25 square miles. It is the firstsystem in the Northern Virginia area to place AutoPulse devices on allof its responding units. According to Sterling's Chief Byron F.Andrews, III, "We believe the AutoPulse is a tool that helps ourmedics give patients a better chance at surviving cardiac arrest. Byproviding automated and uninterrupted chest compressions, medics canfocus on other life-saving interventions. The AutoPulse helps themimprove resuscitation efforts so that they believe they are doingeverything they can for the victim. I cannot say enough about thebenefits of the AutoPulse in terms of its ability to improvecirculation and our efforts to help cardiac arrest victims."

VCU Medical Center Study Showed Improved Survival to Discharge

A recent study, completed in conjunction with Richmond AmbulanceAuthority (RAA), compared 499 manual CPR cases and 284 cases usingautomated CPR, which involved the use of the AutoPulse. The studyanalyzed out-of-hospital cardiac arrest cases between January 2001 andMarch 2005 and evaluated data before and after RAA paramedics beganusing the AutoPulse. Overall, the data showed asurvival-to-hospital-discharge rate of 9.7 percent using automatedCPR, compared with 2.9 percent using manual chest compressions.According to its Medical Director Joseph P. Ornato, M.D., RAA is thefirst EMS agency in the country to have shown that significantly morepatients survive and are discharged from the hospital with use of theAutoPulse.

Other Virginia agencies that currently use the AutoPulse as partof their resuscitation efforts include Christiansburg Rescue Squad,Chase City Rescue Squad, Colonial Heights Fire & Rescue, CumberlandCounty EMS, Ettrick Matoaca Rescue Squad, Ford Volunteer FireDepartment, Gloucester Emergency Service, Gloucester Volunteer Fire &Rescue, Henrico Volunteer Rescue Squad, James City County FireDepartment, James City Volunteer Rescue Squad, Kilarnock LancasterVolunteer Rescue, Lakeside Volunteer Rescue, Manchester VolunteerRescue Squad, Mathews Volunteer Rescue Squad, Medical College ofVirginia Hospital, Mid-County Public Safety Equipment, MiddlesexVolunteer Rescue Squad, Midway Volunteer Fire Department, MonetaVolunteer Ambulance, Montross Volunteer Rescue Squad, Powhatan CountyFire Department, Providence Forge Volunteer Rescue, Richmond AmbulanceAuthority, Richmond Fire Department, Southside Virginia Emergency, andTuckahoe Volunteer Rescue. More than 235 EMS agencies and hospitalsworldwide employ the AutoPulse.

About the AutoPulse

New AHA 2005 Guidelines note that interrupting chest compressionscan decrease the rate of survival from cardiac arrest.(a) TheAutoPulse is an automated, portable device with a simple,load-distributing LifeBand(R) that squeezes the entire chest in aconsistent, uninterrupted "hands-free" manner, delivering maximumblood flow to the heart and brain.(a) Additionally, it offers thebenefit of freeing up rescuers to focus on other life-savinginterventions.

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologiesthat help advance the practice of resuscitation. With products forpacing, defibrillation, circulation, ventilation, and fluidresuscitation, ZOLL provides a comprehensive set of technologies thathelp clinicians, EMS professionals, and lay rescuers resuscitatesudden cardiac arrest or trauma victims. ZOLL also designs and marketssoftware that automates the documentation and management of bothclinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries.The Company has direct operations, distributor networks, and businesspartners throughout the U.S., Canada, Latin America, Europe, theMiddle East, Asia, and Australia. For more information, visitwww.zoll.com or call +1 (978) 421-9655.

Certain statements contained in this press release regardingmatters that are not historical facts are "forward-looking" statements(as defined in the Private Securities Litigation Reform Act of 1995).Because such statements are subject to risks and uncertainties, actualresults may differ materially from those expressed or implied by suchforward-looking statements. Factors that could cause actual results todiffer materially from those expressed or implied by suchforward-looking statements include, but are not limited to, ZOLL'sability to compete in the resuscitation business; acceptance of theAutoPulse; changes in regulations affecting the healthcare industry;general economic conditions; and those other factors discussed in thesection entitled "Risk Factors" in ZOLL's Annual Report on Form 10-Q,which was filed with the SEC on February 10, 2006.

(C) 2006 ZOLL Medical Corporation. All rights reserved. 269 MillRoad, Chelmsford, MA 01824-4105. AutoPulse, LifeBand, and ZOLL areregistered trademarks of ZOLL Medical Corporation. All product namesare the property of their respective owners.

(a)Clinical data available upon request.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Zoll Medical Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Zoll Medical Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 161,63 -1,63%